Awards, Honors and Membership in Honorary Societies:

September 1987	Walle A. Natute Award in Neural Sciences, University of Rochester School of Medicine and Dentistry. I was selected among my classmates for showing the most clinical insight and intellectual excellence in the neural sciences, as well as an enthusiasm for learning and teaching.
November 1989	Alpha Omega Alpha Honor Society. Elected during my senior year at the University of Rochester School of Medicine and Dentistry.
May 1990	The Doran J. Stephans Prize, University of Rochester School of Medicine and Dentistry. I was awarded this prize by the medical alumni. It is given to a student who shows "promise of developing the personal and professional qualities that distinguished the late Dr. Doran Stephans, a graduate of the first class of the school, an inspiring teacher, talented investigator, kindly and able physician."
May 1990	The George Trombetta Prize, University of Rochester School of Medicine and Dentistry. I was awarded this prize by the Department of Obstetrics and Gynecology. This prize is given to a student whose "outstanding performance in obstetrics and gynecology best exemplifies Dr. Trombetta's dedication to scholarship, interest in teaching, and kindness and concern for patients and colleagues."
May 1990	Outstanding Scholastic Achievement in Medical School. Commended by the American Medical Women's Association.

Membership in Professional and Scientific Societies:

April 1987-June 1990	Member of the Medical Society of the State of New York Committee on Publications and Archives. I was appointed to this position by the Medical Society of the State of New York.
1996-Present	Member, American Urogynecologic Society
1996-Present	Physician member, Interstitial Cystitis Association
1996-Present	Physician member, National Association for Continence
1998-Present	Fellow, The American College of Obstetricians and Gynecologists
2000-Present	Member, North American Menopause Society
2002-Present	Member Coding Committee, American Urogynecologic Society

Editorial Positions:
None

Academic Committees at the University of Pennsylvania:

January 1994-1996

Medical Student Education Committee, Department of Obstetrics and Gynecology, University of Pennsylvania Medical Center, Philadelphia, PA

Major Teaching and Clinical Responsibilities for the University of Pennsylvania:

Lectures by Invitation:

October 18, 1996	Society of Urologic Nurses and Associates(SUNA). "Urogential changes and the menopause." Conshohocken, PA
November 1996, November 1997	Philadelphia, PA. Lecture on incontinence. Part of Penn Health for Women Seminar to the public.
December 1999	Painful Bladder Syndrome. Update in Urogynecology conference sponsored by Good Samaritan Hospital. Phoenix, Arizona
March 2000	Incontinence in Women. Juno Women's Fair, Fort Wayne, IN
April 2000	Female Incontinence. Women's Health 2000 Conference (CME) Fort Wayne, IN
May 4, 2000	Healthline-Common Urogynecology Problems. Public Television appearance, live call-in show.

Organizing Roles in Scientific Meetings:
None

Bibliography:

Research Publications, Peer Reviewed

• Sherer DM, Singh GS, Woods JR. Transvaginal sonographic diagnosis of an unruptured interstitial pregnancy. Journal of Clinical Ultrsound 1990;7:582-5.
• Singh GS, Aikins JK, Deger R, King S, Mikuta JJ. Metastatic cervical cancer and pelvic inflammatory disease in an AIDS patient. Gynecologic Oncology 1994;3:372-6.
• Rigsby D, Singh GS. Asymptomatic microscopic hematuria in women. International Urogynecology Journal, 1999;10: 361-64.
• Bradley CS, Singh GS. Interstitial Cystitis. The Female Patient. 2000;25:83-88

Research Publications, Non-Peer Reviewed

• Aikins JK, Singh GS, Mikuta JJ. Evaluation and significance of abnormal vaginal bleeding. Postgraduate Obstetrics 1994;14:14.
• Singh GS, Bader TJ. Commentary on endometriosis externa in post cesarean section scars. Resident Staff Physician. 1996;24(8):26-34.
• Singh GS. Team-based management of interstitial cystitis. Contemporary Urology, (Suppl.) Medical Economics, Co., 1997.
• Singh GS, Mama S. Interstitial cystitis. Postgraduate Obstetrics. Vol. 18. 21 Oct. 1998

Abstracts

October 1995	Seattle, WA. Oral Presentation: Technical tricks - A unique disinfection system for flexible endoscopes. Annual Meeting of the American Urogynecologic Society
October 1996	New Orleans, LA. Poster presentation: Periurethral contigen implant for the treatment of type III stress urinary incontinence. Annual Meeting of the American Urogynecologic Society.
September 1997	Tuscon, AZ. Oral presentation. Interstitial cystitis and pregnancy. Annual Meeting of the American Urogynecologic Society.
October 1997	Washington, D.C. Oral presentation. Interstitial cystitis and pregnancy. Annual Interstitial Cystitis Association Meeting.
November 1998	Washington D.C. Oral presentation. Asymptomatic microscopic hematuria. Annual Meeting of the American Urogynecologic Society.
November 1998	Washington D.C. Oral presentation. A survey of current practice patterns among primary care physicians for the management of female urinary incontinence. Annual Meeting of the American Urogynecologic Society.
October 1999	San Diego, California. Poster presentation: Chronic pelvic pain and interstitial cystitis, a case series. Annual Meeting of the American Urogynecologic Society.
October 1999	San Diego, California. Poster presentation: Urinary symptoms in the puerperium. Annual Meeting of the American Urogynecologic Society.

Editorials, Reviews, Chapters

• Singh GS. Pelvic Organ Prolapse (chapter) in Veet L. (ed) Case studies in Women's Health. Henley and Belfus Medical Publishers, Philadelphia, PA, in press
• Veet L. (ed). Case Studies in Women's Health. Singh GS. Contributing reviewer. Henley and Belfus Medical Publishers, Philadelphia, PA in press

Activities and Interests: Gourmet cooking. I won first prize ($5000) and second prize ($1000) in the National Courvoisier Cooking Contest in August 1986. In November 1994, I won a contest for holiday desserts and prepared the recipes on public television. In April 1999 I was a finalist in a contest sponsored by Healthy Choice Products and competed on stage with Graham Kerr as emcee.
Painting and pottery.
Antiquing and furniture restoration.

Research:

1. A Phase III, Multicenter, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of Controlled Release XXXX vs. XXXX in the Treatment of Patients with Overactive Bladder.
2. A Randomized, Double-blind, Placebo Controlled, Parallel Group, Fixed-Dose, Dose-Ranging Study to Assess The Safety and Efficacy of Daily Administration of a Single Oral Dose of XXXX in Male and Female Patients with Urge Urinary Incontinence.
3. A Phase II, Randomized, Double-blind, Parallel Group, Placebo Controlled, Twelve Week Pilot Study to Evaluate the Safety and Efficacy of J956 Administered with Estrogen to Post-Menopausal Women.
4. A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi Center Study to Assess Efficacy and Safety of Daily Oral Administration of XXXX versus Placebo in Male and Female Subjects with Overactive Bladder.
5. Efficacy and Safety of XXXX Compared with Placebo in Subjects with Stress Urinary Incontinence.
6. Long Term Monitoring of Safety in Subjects Treated with XXXX for Stress Urinary Incontinence.
7. A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Study of the Efficacy and Safety of XXXX Cream in Premenopausal Patients With Female Sexual Arousal Disorder.
8. Randomized, Placebo-Controlled, Double-Blind, Crossover Design Pilot Trial of the Efficacy and Safety of XXXX for Women in Women with Female Sexual Arousal Disorder.
9. Preliminary Efficacy Study in Pre-menopausal Women With Normal or Impaired Sexual Function Due to Acquired Arousal and/or Orgasm Disorder Comparing XXXX 1.0mg to Placebo: Double-Blind with 8-Week Home Treatment Phase.
10. Prospective, Randomized, Double-Blind, Placebo-Controlled Evaluation of Topical XXXX Administered At Home For The Treatment of Women With Female Sexual Arousal Disorder (FSAD).
11. XXXX to the Submucosa of the Bladder Outlet and Proximal Urethra for the Treatment of Stress Urinary Incontinence.
12. A Phase 3B Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of XXXX in Subjects with Overactive Bladder.
13. A Phase III, Multinational, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled 24-week Study to Evaluate the Efficacy and Safety of XXXX in Naturally Menopausal Women with Hypoactive Sexual Desire Disorder on Concurrent Oral Hormone Replacement Therapy.
14. A Phase III, Multinational, Randomized, Double-Blind, Parallel Group, Placebo-Controlled 24-week Study to Evaluate the Efficacy and Safety of XXXX in Women with Hypoactive Sexual Desire Disorder on Concurrent Estrogen Replacement Therapy Who Have Undergone Hysterectomy and Bilateral Oophorectomy.
15. Identifying Bladder Origin Pelvic Pain/Interstitial Cystitis in Gynecologic Patients and Their Treatment with XXXX vs. Placebo.
16. A Randomized, Double-Blind, Placebo-Controlled, Fixed Dose, Multi-Center Study to Evaluate the Efficacy, Safety and Toleration of Oral XXXX Administered for 12 Weeks to Post-Menopausal Women Who Have Been Diagnosed With Female Sexual Arousal Disorder.
17. A Randomized, Double-Blind, Double Dummy, Placebo-Controlled, Fixed Dose, Multi-Center Study to Evaluate the Efficacy, Safety and Toleration of Oral XXXX Administered for 12 Weeks to Pre-Menopausal Women Who Have Been Diagnosed With Female Sexual Arousal Disorder.
18. Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Partial XXXX, in Women with Stress Urinary Incontinence or Mixed Urinary Incontinence.

Revised January 7, 2003